Mankind Pharma IPO Date, Price, Review
Mankind Pharma IPO: Know everything about Mankind Pharma IPO. Mankind Pharma Limited IPO Date, Mankind Pharma IPO Review and analysis. We will discus about Mankind Pharma IPO Benefits & Risks. Also, all information related to Mankind Pharma IPO like price band, all important dates, issue size, Brockrage Review, and retail quota etc.
Mankind Pharma IPO
Mankind Pharma is one of the largest pharmaceutical companies in India (based on domestic sales). Mankind Pharma Ltd Has filed its DRHP (Draft Red Herring Prospectus) with market regulator SEBI (Securities and Exchange Board of India) to raise around Rs - crore through IPO (Initial public offering).
Mankind Pharma IPO will open on 25 April 2023 and close on 27 April 2023. The price band of the Mankind Pharma IPO is ₹1026 to ₹1080. Mankind Pharma IPO size is 4326 Crores. The offer includes [0] Crores under fresh issue and 4326 Crores under offer for sale. Mankind Pharma IPO QIB quota is 50%, NII quota is 15% and RII quota is 35%. Mankind Pharma IPO listing date is 08 May 2023. You can know about Mankind Pharma IPO GMP (Grey Market Premium) below.
Mankind Pharma has given good financial performance. The company made a profit of ₹1452 crores in the financial year 2022. The IPO of Mankind Pharma will be listed on NSE and BSE. Mankind Pharma IPO face value is ₹1 per equity share.
We will talk about Mankind Pharma financials, benefits, and risks of investing in the company.
About Mankind Pharma International Ltd
Mankind Pharma was incorporated in the year 1991. Presently Mankind Pharmaceuticals is one of the largest pharmaceutical companies in India (based on domestic sales). The company is engaged in the development, manufacturing, and marketing of a variety of Pharmaceutical Formulations of Health Products.
The company operates 23 manufacturing facilities across India including the states of Sikkim, Himachal Pradesh, Rajasthan, Uttarakhand, and Andhra Pradesh as on March 31, 2022. Apart from India, the company's major markets include the United States, Sri Lanka, Bangladesh, and Nepal.
Apart from branded generic drugs, Mankind Pharma's flagship products include Prega-News Pregnancy Testing Kit, Manforce Condom, Gas-O-Fast Ayurvedic Antacid, and acne treatment drug Acnestar.
Purpose of the offer
- To prepay/repay all or a part of the dues raised by the company.
- To finance capital expenditure requirements.
- To meet general corporate objectives.
Mankind Pharma IPO Date and Price Band Details
| IPO Open: | 25 April 2023 |
| IPO Close: | 27 April 2023 |
| Listing Date: | 08 May 2023 |
| Listing On: | NSE & BSE |
| IPO Size: | Approx ₹4326 crores |
| Fresh Issue: | Approx ₹- crores |
| Offer For Sale: | Approx ₹4326 crores |
| Price Band: | ₹1026 to ₹1080 per share |
| Face Value: | ₹1 per Equity share |
| QIB Portion: | 50% |
| Retail Portion: | 35% |
| NII Portion: | 15% |
| Employee Res: | Not Disclosed |
Mankind Pharma IPO Lot Size Details
| Minimum Lot: | 01 |
| Minimum Lot Size: | 13 Shares |
| Minimum Amount: | ₹14,040 |
| Maximum Lot: | 13 |
| Maximum Lot Size: | 182 Shares |
| Maximum Amount: | ₹196,560 |
Mankind Pharma IPO Open, Close, Allotment, and Listing Date
| Ipo Opening Date: | 25 April 2023 |
| IPO Closing Date: | 27 April 2023 |
| Basis of Allotment: | 03 May2023 |
| Refund Date: | 04 May 2023 |
| Credit to Demat Account: | 05 May 2023 |
| Listing Date: | 08 May 2023 |
Mankind Pharma IPO Review
| Happiest Post | Apply |
| Aditya Birla Ltd | Apply |
| Canara Bank | Apply |
| Axis Capital | Not Rated yet |
| HDFC Securities | Not Rated yet |
| ICICI Direct | Apply |
| Kotak Securities | Not Rated yet |
| Motilal Oswal | Not Rated yet |
| Ventura Securities Ltd | Apply |
You can also check the latest IPO subscription status and IPO allotment status of Mankind Pharma IPO on our website.
Mankind Pharma Ipo Rating
Review For Listing Gain
Review For Short term
Review For Long term
Strength
- Mankind Pharma Limited has market-leading rankings with a diversified portfolio.
- Mankind Pharma Limited is a reputed and well-known brand.
- The company has a wide market and distribution reach with an emphasis on accessibility and cost.
- The company has an experienced and dedicated senior management team.
- The company has capabilities for production and R&D that are comprehensive and diverse.
Risks
- If the companies do not comply with the necessary regulations laid down by the governments and relevant regulatory authorities, their business, reputation, financial condition, and operating results will suffer.
- Any interruption, slowdown, or interruption in a company's manufacturing or R&D processes can have a negative impact on its financial performance.
- The company serves a small number of markets, yet these markets account for a large portion of its revenue.
- The company depends on its medical agents, distributors, and traders for the sale and distribution of its products.
Mankind Pharma Ltd Financials
Mankind Pharma Financials(in Crores)
| Year | Total Assets | Revenue | Profit |
|---|---|---|---|
| 2019 | ₹- | ₹- | ₹- |
| 2020 | ₹5,073.29 | ₹5,975.65 | ₹1,056.15 |
| 2021 | ₹6,372.63 | ₹6,385.38 | ₹1,293.03 |
| 2022 | ₹9,147.74 | ₹7,977.58 | ₹1,452.96 |
Promoters
- Ramesh Juneja, Rajeev Juneja
- Sheetal Arora
- Ramesh Juneja Family Trust
- Rajeev Juneja Family Trust
- Prem Sheetal Family Trust
Contact Details of Mankind Pharma
208, Okhla Industrial Estate
Phase-III,
New Delhi 110020, India
Telephone: +91 11 4684 6700
E-mail: investors@mankindpharma.com
Website:https://www.mankindpharma.com/
Mankind Pharma Lead Managers
- IIFL Securities Limited
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- J.P. Morgan India Private Limited
- Jefferies India Private Limited
Mankind Pharma IPO Registrars
Telephone: Phone: 04067162222, 04079611000
Email: mankind.ipo@kfintech.com
Website:https://karisma.kfintech.com/
Conclusion
Looking at the financial position of Mankind Pharma Private Ltd, the track record has been good. In the financial year 2022, the company had a profit of Rs 1452.96 crore. The company has a diversified product portfolio. Our suggestion is that you can apply for long-term on the third day after seeing IPO Subscription numbers. Mankind Pharma Limited IPO financial details and other information are given above.
Mankind Pharma IPO FAQs
How to Apply the Mankind Pharma Ltd IPO with Zerodha?
We hope you like this article about Mankind Pharma IPO. If you have a query about Mankind Pharma IPO then, leave a comment. Here you can also stay updated about the upcoming IPO. Also, you can track IPO performance. Thanks for Visiting. Happy Investing.
0 Comments
We are waiting for your comments. 💙